Prevalence of Infant Nonsupine Sleep Position Steady From 2016 to 2022
By Lori Solomon HealthDay Reporter
WEDNESDAY, Dec. 18, 2024 -- The overall prevalence of nonsupine sleep positions during infancy has been steady over time (2016 to 2022), according to a research letter published online Dec. 12 in JAMA Network Open.
Guodong Ding, Ph.D., M.D., from Shanghai Jiao Tong University in China, and colleagues analyzed temporal changes in the prevalence of nonsupine sleep position among U.S. infants at 4, 6, 9, and 12 months of age. The analysis included data from 9,396 infants identified from the National Survey of Children’s Health (2016 to 2022).
The researchers found that the overall prevalence of nonsupine sleep position was 12.0 percent at 4 months, 12.9 percent at 6 months, 19.2 percent at 9 months, and 23.0 percent at 12 months of age. Prevalence rates varied sociodemographically, with a substantially higher prevalence among Black infants and infants from low-income, low-education, and smoking households. Over time, there were no significant temporal changes in the prevalence of nonsupine sleep position across ages. At 9 and 12 months, downward trends in nonsupine sleep position expanded to other racial and ethnic groups and higher education households. At 4 months, an upward trend in nonsupine sleep position occurred among Hispanic infants.
"The overall prevalence of nonsupine sleep positions during infancy remained stable over the seven-year study period, suggesting no changes in parental behavior toward the sleep hygiene of their infants," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-19 06:00
Read more

- Postpandemic Hospital Occupancy Up to 73.5 Percent, Sparking Concern
- FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
- FDA Approves Journavx, First New Non-Opioid Pain Pill in Decades
- More Than Two-Thirds of U.S. Counties Do Not Have a Gastroenterologist
- De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
- Trump Administration Reverses Plan to End Free COVID Test Program
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions